| Article | Date | Source |
|---|
| Teva Snatches Cephalon from Valeant | -- | News - BioPharm |
| Cephalon splashes out on mesenchymal stem cells | -- | Nature Biotechnology |
| Cephalon cancer drug, in combo therapy, kills multiple myeloma cells in mice | August 14, 2012 | FierceBiotech Research |
| Teva wins round in fight against generics for Cephalon drug Amrix | April 17, 2012 | Health News - BizJournals.com |
| Teva's Cephalon recalls leukemia drug over fragments in vial | January 31, 2012 | FiercePharma Manufacturing |
| Recall for Cephalon leukemia drug | January 30, 2012 | Health News - BizJournals.com |
| Former Cephalon counsel joins firm | January 05, 2012 | Health News - BizJournals.com |
| Teva jacks up prices on Cephalon legacy brands | December 07, 2011 | FiercePharma |
| Impax Sued by Teva’s Cephalon Over Fentora Pain Drug Patents | November 21, 2011 | Pharmaceutical - Moreover |
| Relatively High Sales per Share Detected in Shares of Cephalon in the Biotechnology Industry (CEPH, BIIB, AMGN, UTHR, CBST) | October 27, 2011 | Biotechnology - Moreover |
| Requiem for Doomed Drug Patents: Merck and Teva/Cephalon Will Bid Farewell to Blockbusters - cbl | October 26, 2011 | Pharmaceutical - Moreover |
| Acino Acquires Cephalon's Middle East and African Business | October 20, 2011 | Pharmaceutical - Moreover |
| EU approves takeover of Cephalon by Teva [Kuwait News Agency] | October 18, 2011 | Pharmaceutical - Moreover |
| Teva wraps up Cephalon acquisition | October 17, 2011 | Pharmaceutical - Moreover |
| Teva decides fate of Cephalon offices | October 17, 2011 | Health News - BizJournals.com |
| Swiss firm to acquire Cephalon's ME business | October 16, 2011 | Pharmaceutical - Moreover |
| Teva, Cephalon Win EU Antitrust OK For $6.8B Tie-Up | October 14, 2011 | Pharmaceutical - Moreover |
| Teva to maintain Cephalon offices in Frazer, Pa., after merger | October 14, 2011 | Health News - BizJournals.com |
| Teva Pharma closes Cephalon acquisition | October 14, 2011 | Health News - CNBC |
| Teva to take $13m spanner from works to close $6.8bn Cephalon deal | October 14, 2011 | Pharmaceutical - Moreover |
| EU approves takeover of Cephalon by Teva | October 14, 2011 | Pharmaceutical - Moreover |
| Teva wraps Cephalon buy, agrees to sell Provigil copy | October 14, 2011 | FiercePharma |
| Teva Pharma Closes Cephalon Acquisition - Quick Facts | October 14, 2011 | Pharmaceutical - Moreover |
| Teva-Cephalon combination official, will have $20B in revenues | October 14, 2011 | Health News - BizJournals.com |
| EU Clears Cephalon's Sale to Israeli Drugmaker Teva | October 14, 2011 | Pharmaceutical - Moreover |
| UPDATE: Teva Completes Acquisition of Cephalon; Cephalon Ceased Trading Today | October 14, 2011 | Pharmaceutical - Moreover |
| Cephalon sale closing today | October 14, 2011 | Health News - BizJournals.com |
| EU clears buy of Cephalon by Israel's Teva | October 14, 2011 | Pharmaceutical - Moreover |
| EU Clears Buy Of US Pharma Company Cephalon By Israel's Teva | October 14, 2011 | Pharmaceutical - Moreover |
| Mergers: Commission approves the acquisition of Cephalon by Teva, subject to conditions | October 14, 2011 | Pharmaceutical - Moreover |
| Teva, Cephalon Receive European... | October 14, 2011 | Pharmaceutical - Moreover |
| Highest Sales per Share in the Biotechnology Industry Detected for Cephalon ... | October 13, 2011 | Biotechnology - Moreover |
| Teva, Cephalon get European approval on merger | October 13, 2011 | Pharmaceutical - Moreover |
| CEPHALON: Teva and Cephalon Receive European Commission Approval For Acquisitio.. | October 13, 2011 | Pharmaceutical - Moreover |
| BRIEF-Teva and Cephalon receive European commission approval for acquisition | October 13, 2011 | Pharmaceutical - Moreover |
| Teva’s Cephalon Bid Clears Final Hurdle With European Approval | October 13, 2011 | Pharmaceutical - Moreover |
| Teva, Cephalon closer to cinching $7B merger | October 13, 2011 | Health News - BizJournals.com |
| Teva and Cephalon Receive European Commission Approval For Acquisition | October 13, 2011 | Pharma News - Business Wire |
| Cephalon to be replaced by TE Connectivity in S&P | October 12, 2011 | Health News - BizJournals.com |
| TE Connectivity (TEL) to Replace Cephalon (CEPH) in S&P 500 | October 12, 2011 | Pharmaceutical - Moreover |
| Cephalon (CEPH) to be replaced by TE Connectivity (TEL) in the S&P 500 | October 11, 2011 | Pharmaceutical - Moreover |
| FTC blesses Teva's Cephalon buy, with caveats | October 11, 2011 | Pharmaceutical - Moreover |
| Teva To Get EU OK For Cephalon Takeover -Reuters | October 10, 2011 | Pharmaceutical - Moreover |
| Teva Pharmaceutical ([[TEVA +2.2%) moves higher this morning after the FTC approved its merger with Cephalon ([[CEPH +0.4%) over the weekend. As part of the approval, Teva is required to divest two abbreviated new drug applications for fentanyl citra | October 10, 2011 | Pharmaceutical - Moreover |
| Teva-Cephalon merger OK’d by FTC with conditions | October 10, 2011 | Health News - BizJournals.com |
| FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Teva's $6.8 Billion Acquisition of Cephalon (10/7/11) | October 08, 2011 | Pharmaceutical - Moreover |
| Teva Must Surrender Generics To Get Cephalon: FTC | October 08, 2011 | Pharmaceutical - Moreover |
| UPDATE 2-Teva gets US okay to buy Cephalon with conditions | October 07, 2011 | Pharmaceutical - Moreover |
| FTC gives initial OK to Teva-Cephalon deal; divestiture required | October 07, 2011 | Pharmaceutical - Moreover |
| BRIEF-Teva's acquisition of Cephalon gets FTC clearance | October 07, 2011 | Pharmaceutical - Moreover |
| Feds probe Cephalon on Provigil, Nuvigil promos | October 03, 2011 | FiercePharma |
| DOJ Probes Cephalon Over Narcolepsy Drug Marketing | September 30, 2011 | Pharmaceutical - Moreover |
| Cephalon gets Provigil, Nuvigil marketing subpoena | September 30, 2011 | Pharmaceutical - Moreover |
| UPDATE 1-Cephalon gets subpoena from U.S. DOJ | September 30, 2011 | Pharmaceutical - Moreover |
| Biotech 2011 speakers list includes Merck, Cephalon execs | September 30, 2011 | Biotechnology - Moreover |
| U.S. Slaps Cephalon With Subpoena In Leukemia Drug Probe | September 27, 2011 | Pharmaceutical - Moreover |
| US Seeks Leukemia Drug Docs In Cephalon Marketing Probe | September 27, 2011 | Pharmaceutical - Moreover |
| Feds cite HIPAA in subpoena on Cephalon's Treanda | September 27, 2011 | FiercePharma |
| Teva offers EU watchdog concessions for Cephalon buy | September 23, 2011 | Pharmaceutical - Moreover |
| Cephalon Challenges Sun's Anti-Epilepsy Generic | September 22, 2011 | Pharmaceutical - Moreover |
| BRIEF: Cephalon shareholders approve acquisition by Teva | August 07, 2011 | Pharmaceutical - Moreover |
| Cephalon Reported Financial Results for the Second Quarter of 2011 | August 02, 2011 | Biotech News - PR Newswire |
| Teva-Cephalon merger set for Oct., no word on whether layoffs will occur | July 27, 2011 | Health News - BizJournals.com |
| USF Polytechnic assists Cephalon in cancer drug production | July 21, 2011 | Health News - BizJournals.com |
| Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ | July 21, 2011 | Pharma News - PR Newswire |
| Cephalon shareholders approve sale to Teva | July 14, 2011 | Health News - CNBC |
| Cephalon Says Stockholders Agree To Acquisition By Teva | July 14, 2011 | Pharmaceutical - Moreover |
| BRIEF-Cephalon says shareholders approve acquisition by Teva | July 14, 2011 | Pharmaceutical - Moreover |
| Cephalon shareholders OK takeover by Teva, regulatory approval pending | July 14, 2011 | Health News - BizJournals.com |
| Cephalon Shareholders Approve Acquisition by Teva (PRN) | July 14, 2011 | Pharmaceutical - Moreover |
| Cephalon Shareholders Approve Acquisition by Teva | July 14, 2011 | Biotech News - PR Newswire |
| Feds probe Cephalon's Treanda marketing | July 12, 2011 | FiercePharma |
| US Asks Cephalon For Data On Promotion Of Drug Treanda -Report | July 11, 2011 | Pharmaceutical - Moreover |
| Cephalon drug Treanda passes $1B in sales | July 08, 2011 | Health News - BizJournals.com |
| Cephalon to Release Second Quarter 2011 Earnings Results After the Market Close on August 2, 2011 | June 29, 2011 | Medical Pharma - PR Newswire |
| Teva/Cephalon deal faces delay | June 15, 2011 | Pharmaceutical - Moreover |
| Teva's Cephalon acquisition could be delayed | June 15, 2011 | Pharmaceutical - Moreover |
| US FTC seeks more information from Teva, Cephalon on merger | June 15, 2011 | Pharmaceutical - Moreover |
| FTC seeks additional information from Teva & Cephalon regarding merger | June 14, 2011 | Pharmaceutical - Moreover |
| FTC goes back to Teva on Cephalon deal | June 14, 2011 | FiercePharma |
| Israel stocks up; FTC eyes Teva-Cephalon deal | June 14, 2011 | Pharmaceutical - Moreover |
| TEVA PHARMACEUT. ADR: Teva and Cephalon Receive FTC Request for Additional Information | June 14, 2011 | Pharmaceutical - Moreover |
| Teva and Cephalon Receive FTC Request for Additional Information | June 13, 2011 | Pharma News - Business Wire |
| Who Valeant wants to replace on Cephalon board | June 04, 2011 | Health News - BizJournals.com |
| Proxy fight on as Valeant names candidates for Cephalon board | June 04, 2011 | Health News - BizJournals.com |
| Cephalon says no to takeover | June 04, 2011 | Health News - BizJournals.com |
| Cephalon CEO up for $14M severance in Teva deal | June 03, 2011 | FiercePharma |
| Cephalon Inc.: PharmaVitae Profile: New research report available at Fast Market Research | May 31, 2011 | Pharmaceutical - Moreover |
| Cephalon wins restraining order against Mylan | May 20, 2011 | Health News - CNBC |
| Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation | May 20, 2011 | Biotech News - PR Newswire |
| Cephalon Investor Meeting Takeaways on Acquisiton by Teva: Analyst | May 19, 2011 | Pharmaceutical - Moreover |
| STEM cell developer Mesoblast dropped 5.7% on no news to close at $8.72 compared with topping the board last week by adding 13.5% after Israeli-based Teva Pharmaceutical Industries agreed to buy Mesoblast investor Cephalon for $US6.8 billion. | May 16, 2011 | Pharmaceutical - Moreover |
| BRIEF: Teva wins patent suit against newly acquired Cephalon [Globes, Tel Aviv, Israel] | May 15, 2011 | Pharmaceutical - Moreover |
| Teva wins patent fight, Cephalon may appeal | May 13, 2011 | Health News - BizJournals.com |
| Cephalon Recognizes National Night Shift Worker's Day, Honors America's Shift Workers | May 11, 2011 | Medical Pharma - PR Newswire |
| Teva Makes Splash Into Brand Drugs, Acquires Cephalon for $6.8 Billion | May 10, 2011 | Pharmaceutical - Moreover |
| AFTER a big week on the share market, stem cell developer Mesoblast topped the board adding 13.5% after Israeli-based Teva Pharmaceutical Industries agreed to buy Mesoblast investor Cephalon for $US6.8 billion. | May 10, 2011 | Pharmaceutical - Moreover |
| Teva's Cephalon Acquisition Strengthens Branded Business | May 08, 2011 | Pharmaceutical - Moreover |
| Cephalon Presents Positive Results with NUVIGIL in Largest Shift Work Disorder Trial Ever Conducted | May 06, 2011 | Pharma News - PR Newswire |
| Cephalon rejects Valeant takeover bid | May 04, 2011 | Health News - BizJournals.com |
| Cephalon Earnings: Double-Digit Revenue Growth for Fifth Straight Quarter | May 03, 2011 | Pharmaceutical - Moreover |
| Valeant looks past Cephalon to other deals | May 03, 2011 | Pharmaceutical - Moreover |
| Cephalon 1Q profit surges on investment gain | May 03, 2011 | Health News - CNBC |
| S&P: Teva Pharmaceutical Industries Ltd. Ratings Affirmed On Agreement To Buy Cephalon Inc. For $6.8B | May 03, 2011 | Pharmaceutical - Moreover |
| European Commission opens investigation against Cephalon and Teva | May 03, 2011 | Pharmaceutical - Moreover |
| Cephalon accepts Teva's $6.8 billion white knight bid | May 03, 2011 | Pharmaceutical - Moreover |
| Cephalon accepts Tevas $6.8 billion takeover, again snubbing Valiants $5.7 billion bid | May 03, 2011 | Biotechnology - Moreover |
| ‘Cephalon Was on Our Radar for Years’ | May 03, 2011 | Pharmaceutical - Moreover |
| Outbidding Valeant, Teva Acquires Cephalon for $6.8 Billion | May 03, 2011 | Pharmaceutical - Moreover |
| Teva Swoops in to Snag Cephalon for $6.8 Billion | May 02, 2011 | Burrill Report |
| Teva to Acquire Cephalon for $6.8 billion | May 02, 2011 | Pharmaceutical - Moreover |
| Cephalon finds great deal with Teva | May 02, 2011 | Pharmaceutical - Moreover |
| Teva Buying Cephalon for $6.8 Billion; Pharmaceutical Industry Today Provides Complete Coverage | May 02, 2011 | Pharmaceutical - Moreover |
| Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction; Withdraws Consent Solicitation | May 02, 2011 | Pharmaceutical - Moreover |
| BRIEF-Moody's affirms Teva A3 rtg on Cephalon deal | May 02, 2011 | Pharmaceutical - Moreover |
| Regeneron, Cephalon boost biotech stocks | May 02, 2011 | Biotechnology - Moreover |
| DealBook: Teva to Buy Cephalon for $6.8 Billion | May 02, 2011 | Pharmaceutical - Moreover |
| Teva to buy Cephalon for $6.8 billion, topping Valeant's unsolicited bid | May 02, 2011 | Pharmaceutical - Moreover |
| Teva buying Cephalon for $6.8 billion
(AP)
| May 02, 2011 | Yahoo Biotech News |
| How Teva, Cephalon compare | May 02, 2011 | Health News - CNBC |
| Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction | May 02, 2011 | Pharma News - PR Newswire |
| Teva Pharmaceuticals to Buy Cephalon for $6.8 Billion in Cash (TEVA) | May 02, 2011 | Pharmaceutical - Moreover |
| Teva Pharmaceuticals Announced It Will Acquire Cephalon For $6.8 Billion (TEVA) | May 02, 2011 | Pharmaceutical - Moreover |
| Summary Box: Teva Pharmaceutical Industries buying Cephalon for $6.8 billion | May 02, 2011 | Pharmaceutical - Moreover |
| UPDATE: TEVA To Buy Cephalon for $6.8 billion; Shares Rise In Pre-Market Trading | May 02, 2011 | Pharmaceutical - Moreover |
| Breakout Stocks: Cephalon Inc.(Nasdaq: CEPH), Teva Pharmaceutical Industries Inc. (Nasdaq: TEVA) | May 02, 2011 | Pharmaceutical - Moreover |
| Teva to Acquire Cephalon | May 02, 2011 | Contract Pharma |
| With $6.8B offer, Teva grabs Cephalon away from Valeant | May 02, 2011 | FiercePharma |
| BRIEF-Cephalon up in premarket trading, Teva to buy | May 02, 2011 | Pharmaceutical - Moreover |
| Teva to Buy Cephalon in $6.8 Billion Transaction (click for story) | May 02, 2011 | Pharmaceutical - Moreover |
| Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid | May 02, 2011 | Pharmaceutical - Moreover |
| BRIEF-Teva, Cephalon shares up in premarket trade | May 02, 2011 | Pharmaceutical - Moreover |
| CORRECTION - NEW YORK - RPT-BRIEF-Teva, Cephalon shares up in premarket trade | May 02, 2011 | Pharmaceutical - Moreover |
| Teva to buy Cephalon for over $6 billion, tops Valeant | May 02, 2011 | Pharmaceutical - Moreover |
| Cephalon acquired by Teva for US$6.8B, beating out hostile bid from Valeant | May 02, 2011 | Pharmaceutical - Moreover |
| Teva Buys Cephalon for $$6.8 Billion | May 02, 2011 | Pharmaceutical - Moreover |
| Cephalon to Release First Quarter 2011 Earnings Results After the Market Close on May 3, 2011 | May 02, 2011 | Medical Pharma - PR Newswire |
| Cephalon likes marriage with Teva | May 02, 2011 | Health News - BizJournals.com |
| Teva buying Cephalon for $6.8 billion | May 02, 2011 | Health News - CNBC |
| Teva strikes deal to buy Cephalon for $6.8B in cash | May 02, 2011 | FierceBiotech |
| Teva to Acquire Cephalon in $6.8 Billion Transaction | May 02, 2011 | Pharma News - Business Wire |
| Antitrust: Commission opens investigation against pharmaceutical companies Cephalon and Teva | April 30, 2011 | Pharmaceutical - Moreover |
| EU probes Teva, Cephalon deal on Provigil generic | April 29, 2011 | FiercePharma |
| EU probes Teva, Cephalon deal on sleeping drug | April 28, 2011 | Health News - CNBC |
| Valeant Pharmaceuticals Responds to Cephalon Board's Letter | April 21, 2011 | Pharma News - PR Newswire |
| Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders | April 21, 2011 | Pharma News - PR Newswire |
| Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders | April 21, 2011 | Biotech News - PR Newswire |
| Valeant flexes its muscles on Cephalon deal | April 21, 2011 | FiercePharma |
| Valeant offers a stick, a carrot and a May 12 deadline to Cephalon investors | April 21, 2011 | FierceBiotech |
| Valeant offers a stick,a carrot and a May 12 deadline to Cephalon investors | April 21, 2011 | FierceBiotech |
| Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors | April 18, 2011 | Pharma News - PR Newswire |
| Relatively High Free Cash Flow per Share Detected in Shares of Cephalon in the Biotechnology Industry (CEPH, BIIB, AMGN, TRGT, UTHR) | April 14, 2011 | Biotechnology - Moreover |
| As it fights takeover, Cephalon looks to complete ChemGenex deal | April 13, 2011 | Health News - BizJournals.com |
| Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals | April 13, 2011 | Pharma News - PR Newswire |
| Valeant may sweeten Cephalon bid | April 11, 2011 | FierceBiotech |
| UPDATE 2-Valeant could raise Cephalon bid if it saw books | April 11, 2011 | Pharmaceutical - Moreover |
| Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders | April 11, 2011 | Pharma News - PR Newswire |
| Cephalon opposes Valeant Pharma's board nominees | April 08, 2011 | Health News - CNBC |
| Cephalon is Among the Companies in the Biotechnology Industry With the Highest Sales per Share (CEPH, BIIB, GENZ, AMGN, CDXS) | April 08, 2011 | Biotechnology - Moreover |
| PREC14A - CEPHALON INC (0000873364) (Subject) | April 07, 2011 | Pharmaceutical - Moreover |
| Cephalon Recommends Shareholders Reject Valeant Nominees | April 07, 2011 | Biotech News - PR Newswire |
| Cephalon Rejects Hostile Bid | April 06, 2011 | Burrill Report |
| Cephalon First Quarter 2011 Earnings Conference Call Tuesday, May 3, 2011 at 5:00 p.m. EDT | April 06, 2011 | Biotech News - PR Newswire |
| Valeant names slate to support Cephalon bid | April 06, 2011 | Health News - CNBC |
| Rejected Valeant aims to replace Cephalon board | April 06, 2011 | FiercePharma |
| Valeant faces a fight after Cephalon rejects offer | April 06, 2011 | FierceBiotech |
| Valeant names potential directors for Cephalon bid | April 06, 2011 | Health News - CNBC |
| Cephalon Board Rejects Valeant’s $73 per Share Unsolicited Takeover Bid | April 06, 2011 | Inside Industry - Gen |
| SC14D9C - CEPHALON INC (0000873364) (Subject) | April 06, 2011 | Pharmaceutical - Moreover |
| Cephalon Board Rejects Valeant’s $5.7B Merger Bid | April 06, 2011 | Pharmaceutical - Moreover |
| Cephalon rejects buyout bid from Valeant | April 05, 2011 | Health News - CNBC |
| Cephalon formerly rejects takeover bid by Canadian pharmaceutical giant Valeant | April 05, 2011 | Pharmaceutical - Moreover |
| Cephalon's Board of Directors Rejects Valeant Pharmaceuticals' Unsolicited Proposal | April 05, 2011 | Medical Pharma - PR Newswire |
| Fund sues Cephalon as Valeant hints at higher bid | April 01, 2011 | FiercePharma |
| Fund sues Cephalon over Valeant bid | April 01, 2011 | FierceBiotech |
| Valeant Launches Hostile Cephalon Bid | April 01, 2011 | Biotechnology - Moreover |
| Valeant has room to move on Cephalon price | March 31, 2011 | FiercePharma |
| Valeant vows to restructure Cephalon as it moves in for the kill | March 31, 2011 | FierceBiotech |
| Valeant may up Cephalon offer if given books | March 31, 2011 | Pharmaceutical - Moreover |
| QuickFacts about Toronto - area Valeant's takeover bid for Cephalon Pharmaceutical | March 31, 2011 | Pharmaceutical - Moreover |
| QuickFacts about Toronto-area Valeant's takeover bid for Cephalon Pharmaceutical | March 30, 2011 | Pharmaceutical - Moreover |
| Biotechnology Stocks Advancing On Cephalon Takeover Offer | March 30, 2011 | Biotechnology - Moreover |
| Valeant Pharmaceutical bids to acquire Cephalon for $5.7 billion | March 30, 2011 | Pharmaceutical - Moreover |
| Investors boost Cephalon past Valeant's $5.7B offer | March 30, 2011 | FiercePharma |
| Valeant Pharmaceuticals Made A Hostile Bid To Acquire Cephalon For About $5.7 Billion (VRX,... | March 30, 2011 | Pharmaceutical - Moreover |
| Valeant Takes Unsolicited $5.7B Cash Offer for Cephalon to Shareholders | March 30, 2011 | Inside Industry - Gen |
| Cephalon shares rocket up after Valeant makes $5.7B hostile bid | March 30, 2011 | FierceBiotech |
| Valeant Takes Unsolicited $5.7M Cash Offer for Cephalon to Shareholders | March 30, 2011 | Inside Industry - Gen |
| Valeant Seeks to Buy Cephalon for $5.7 Billion | March 30, 2011 | Health News - CNBC |
| Sullivan & Cromwell Reps Valeant In $5.7B Cephalon Bid | March 30, 2011 | Pharmaceutical - Moreover |
| Valeant in $5.7bn hostile Cephalon bid | March 30, 2011 | Pharmaceutical - Moreover |
| Cephalon Confirms Receipt of Unsolicited Proposal from Valeant Pharmaceuticals | March 30, 2011 | Medical Pharma - PR Newswire |
| Valeant offering to buy Cephalon for $5.7B | March 29, 2011 | Health News - CNBC |
| Cephalon Makes $231M Overall Bid to Acquire ChemGenex for NDA-Ready CML Drug | March 29, 2011 | Inside Industry - Gen |
| Cephalon continues buyout spree with $163M ChemGenex deal | March 29, 2011 | FierceBiotech |
| Cephalon Makes $231M Overall Bid to Take Over ChemGenex for NDA-Ready CML Drug | March 29, 2011 | Inside Industry - Gen |
| Cephalon to make takeover bid for ChemGenex | March 29, 2011 | Health News - CNBC |
| Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited | March 28, 2011 | Biotech News - PR Newswire |
| Cephalon Claims Fentora Patent Victory | March 28, 2011 | Pharmaceutical - Moreover |
| Cephalon Beefs Up its Cancer Pipeline | March 25, 2011 | Burrill Report |
| Court upholds Cephalon patent for Fentora cancer pain drug | March 25, 2011 | Health News - BizJournals.com |
| Allergan Limited and Cephalon (UK) Limited in breaches of the ABPI Code of Practice | March 25, 2011 | Pharmaceutical - Moreover |
| Allergan and Cephalon breach ABPI code | March 24, 2011 | Pharmaceutical - Moreover |
| Cephalon Wins FENTORA Patent Suit Against Watson | March 24, 2011 | Biotech News - PR Newswire |
| Cephalon Taps Champions for Preclinical Tumorgraft Evaluation of Two Cancer Candidates | March 24, 2011 | Inside Industry - Gen |
| Allergan Limited And Cephalon (UK) Limited Named In Advertisements For Breaches Of The ABPI Code Of Practice | March 23, 2011 | Pharmaceutical - Moreover |
| Cephalon To Acquire Gemin X | March 22, 2011 | Contract Pharma |
| Cephalon to Spend $225M to Purchase Gemin X for Phase II SCLC Candidate | March 22, 2011 | Inside Industry - Gen |
| Cephalon to Spend $225M to Purchase Gemin X for Phase II-Stage SCLC Candidate | March 22, 2011 | Inside Industry - Gen |
| Cephalon Agrees $225M Purchase of Gemin X for Phase II-Stage SCLC Candidate | March 22, 2011 | Inside Industry - Gen |
| Cephalon buying Phila.-area company | March 22, 2011 | Health News - BizJournals.com |
| Cephalon scoops up cancer drugs in $525M Gemin X buyout | March 22, 2011 | FierceBiotech |
| Cephalon to acquire Gemin X for $225M | March 21, 2011 | Health News - CNBC |
| Cephalon to buy Gemin X | March 21, 2011 | Health News - BizJournals.com |
| Cephalon Announces Definitive Agreement to Acquire Gemin X | March 21, 2011 | Pharma News - PR Newswire |
| Cephalon uses Fentora patent disclosures to claim Watson’s generic has unapproved active | March 18, 2011 | Pharmaceutical - Moreover |
| Cephalon sues to block generic Fentora sales, citing dangers | March 16, 2011 | FiercePharma |
| Cephalon names Homcy to its board | March 15, 2011 | Health News - CNBC |
| Cephalon Appoints Charles J. Homcy, M.D. to Board of Directors | March 14, 2011 | Pharma News - PR Newswire |
| Cephalon shares fall after Fentora patents decision | March 14, 2011 | Health News - BizJournals.com |
| Court overturns two patents for Cephalon painkiller | March 14, 2011 | FiercePharma |
| Cephalon Names J. Kevin Buchi as New CEO: PharmaLive Special Reports | March 07, 2011 | Biotechnology - Moreover |
| Cephalon stock downgraded by Jefferies | February 17, 2011 | Health News - BizJournals.com |
| Ahead of the Bell: Cephalon downgraded | February 15, 2011 | Health News - CNBC |
| Cephalon Receives 2011 APhA H.A.B. Dunning Award | February 15, 2011 | Pharmaceutical - Moreover |
| Cephalon buys stake in regenerative medicine firm | February 14, 2011 | Health News - BizJournals.com |
| Cephalon discloses federal Fentora probe | February 14, 2011 | FiercePharma |
| Cephalon subpoenaed by post office regarding Fentora | February 11, 2011 | Health News - BizJournals.com |
| Cephalon shares drop after 4Q earnings report | February 11, 2011 | Health News - CNBC |
| Cephalon Gets Subpoena From US Postal Service About Fentora | February 11, 2011 | Health News - Fox Business |
| Cephalon 4Q profit falls on costs | February 11, 2011 | Health News - CNBC |
| Cephalon 4Q Down 3%, Adjusted Results Rise; Lifts Fiscal Year View | February 10, 2011 | Health News - Fox Business |
| Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 | February 10, 2011 | Biotech News - PR Newswire |
| Cephalon could buy celiac disease drug | February 10, 2011 | Health News - BizJournals.com |
| Cephalon Pays Alba $7M for Option to Purchase Clinical-Phase Celiac Disease Drug | February 10, 2011 | Inside Industry - Gen |
| Cephalon signs Alba Therapeutics option agreement | February 09, 2011 | Health News - CNBC |
| Cephalon has option to buy Alba drug | February 09, 2011 | Health News - BizJournals.com |
| Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics | February 09, 2011 | Biotech News - PR Newswire |
| Lundbeck nabs new rights to Cephalon meds | February 08, 2011 | FiercePharma |
| Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D. (PRN) | January 31, 2011 | Biotechnology - Moreover |
| CORRECTED-UPDATE 1-Cephalon's Nuvigil sails through post-approval study | January 25, 2011 | Biotechnology - Moreover |
| UPDATE 1-Cephalon's Nuvigil sails through post-approval study | January 25, 2011 | Biotechnology - Moreover |
| Cephalon Announces Positive Topline Results From a Phase IV Study of NUVIGIL in Shift Work Disorder | January 25, 2011 | Biotech News - PR Newswire |
| Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D. | January 24, 2011 | Biotech News - PR Newswire |
| Cephalon founder's memorial set for Franklin Institute | January 21, 2011 | Biotechnology - Moreover |
| Recently released market study: Cephalon Inc.: PharmaVitae Profile | January 19, 2011 | Pharmaceutical - Moreover |
| Cephalon is Among the Companies in the Biotechnology Industry With the Highest Free Cash Flow per Share (CEPH, VNDA, OGXI, AMGN, MATK) | January 16, 2011 | Biotechnology - Moreover |
| Cephalon is Among the Companies in the Biotechnology Industry With the Highest ... | January 12, 2011 | Biotechnology - Moreover |
| Cephalon is Among the Companies in the Biotechnology Industry With the Highest Sales per Share (CEPH, BIIB, GENZ, AMGN, MATK) | January 11, 2011 | Biotechnology - Moreover |
| Cephalon's Paul Harmon joins IPHA board | January 10, 2011 | Pharmaceutical - Moreover |
| Pennsylvania Bio to honor Cephalon founder Baldino | January 05, 2011 | Health News - BizJournals.com |
| Cephalon to Evaluate ImmunGene’s mAb-Cytokine Fusion Technology for Six Cancer Targets | January 05, 2011 | Inside Industry - Gen |
| ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology | January 05, 2011 | Biotech News - PR Newswire |
| Cephalon gives up on Nuvigil for jet lag | December 27, 2010 | Health News - BizJournals.com |
| Cephalon ends program on Nuvigil as jet lag drug | December 27, 2010 | Health News - CNBC |
| Cephalon Ends Bid To Get FDA Approval On Nuvigil For Jet Lag | December 27, 2010 | Health News - Fox Business |
| Cephalon Ends Bid To Get FDA Approval On Nuvagil For Jet Lag | December 27, 2010 | Health News - Fox Business |
| Cephalon names new CEO | December 24, 2010 | Pharmaceutical - Moreover |
| Cephalon names J. Kevin Buchi CEO | December 23, 2010 | Health News - CNBC |
| Cephalon Names Buchi As New CEO Following Baldino's Death | December 23, 2010 | Health News - Fox Business |
| Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors | December 23, 2010 | Biotech News - PR Newswire |
| Cephalon demands secret patent-settlement info | December 23, 2010 | FiercePharma |
| Cephalon Wants FTC To Disclose Drug-Industry Patent Deals | December 22, 2010 | Health News - Fox Business |
| Cephalon Wants FTC To Disclose Secret Drug-Industry Patent Deals | December 22, 2010 | Health News - Fox Business |
| Biotech pioneer Frank Baldino of Cephalon dies | December 20, 2010 | Biotechnology - Moreover |
| Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D. (PRN) | December 17, 2010 | Biotechnology - Moreover |
| Cephalon founder, CEO Frank Baldino Jr. dies at 57 | December 17, 2010 | Health News - CNBC |
| Cephalon CEO Baldino Dies While On Medical Leave | December 17, 2010 | Health News - Fox Business |
| Cephalon's Baldino, CEO and founder, dies at 57 | December 17, 2010 | FiercePharma |
| Cephalon co-founder, CEO Frank Baldino dies at 57 | December 17, 2010 | FierceBiotech |
| Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D. | December 17, 2010 | Biotech News - PR Newswire |
| Proteonomix (PROT) Applauds Cephalon Stem Cell Acquisition; Notes Similar Proteonomix StromaCel(R) Technology | December 13, 2010 | Marketwire - Pharma and Biotech |
| Cephalon Makes Big Bet on Stem Cells | December 10, 2010 | Burrill Report |
| Cephalon in up to $1.8 billion alliance with Mesoblast for regenerative medicine, plus stake in the firm | December 10, 2010 | Biotechnology - Moreover |
| Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies | December 08, 2010 | Inside Industry - Gen |
| Cephalon strikes record $2B stem cell pact with Mesoblast | December 08, 2010 | FierceBiotech |
| Cephalon Shells Out $350M to Commercialize Mesoblast MPC Stem Cell Therapies | December 08, 2010 | Inside Industry - Gen |
| Cephalon and Mesoblast Enter Into Strategic Alliance to Develop and Commercialize Novel Therapeutic Products for Regenerative Medicine | December 07, 2010 | Medical Pharma - PR Newswire |
| Cephalon CEO now on indefinite medical leave | December 07, 2010 | FierceBiotech |
| Cephalon CEO on indefinite medical leave� 2 mins ago | December 06, 2010 | Biotechnology - Moreover |
| Cephalon: CEO Baldino's Medical Leave To Be Longer Than Thought | December 06, 2010 | Health News - Fox Business |
| Cephalon CEO on indefinite medical leave | December 06, 2010 | Health News - CNBC |
| Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely | December 06, 2010 | Biotech News - PR Newswire |
| Cephalon to Webcast Investor Day | November 12, 2010 | Pharma News - PR Newswire |
| Cephalon posts jump in 3Q net income | October 29, 2010 | Health News - CNBC |
| Cephalon misses 3Q sales, EPS; raises estimates | October 28, 2010 | Biotechnology - Moreover |
| Cephalon Reports Record Earnings and Raises 2010 Guidance | October 28, 2010 | Biotech News - PR Newswire |
| Shares of Cephalon Rank the Highest in terms of Sales per Share in the Biotechnology Industry (CEPH, BIIB, GENZ, AMGN, MATK) | October 26, 2010 | Biotechnology - Moreover |
| Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL | October 22, 2010 | Pharma News - PR Newswire |
| Cephalon buying BioAssets Development in option | October 22, 2010 | Health News - CNBC |
| Cephalon Invests $15M in ChemGenex and Buys BioAssets Development for $12.5M | October 22, 2010 | Inside Industry - Gen |
| Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations | October 21, 2010 | Biotech News - PR Newswire |
| Cephalon Exercises its Option to Acquire BioAssets Development Corporation | October 21, 2010 | Pharma News - PR Newswire |
| Cephalon Gains FDA Nod on REMS for Antiepileptic Gabitril | October 15, 2010 | Inside Industry - Gen |
| Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL | October 14, 2010 | Biotech News - PR Newswire |
| Impax, Cephalon settle patent challenge | October 13, 2010 | Health News - BizJournals.com |
| Cephalon settles patent dispute over muscle relaxer | October 12, 2010 | Health News - CNBC |
| Eastern Pennsylvania Chapter of The Leukemia & Lymphoma Society Names Cephalon Presenting Sponsor for Light The Night Walk in Chester County | September 30, 2010 | Marketwire - Pharma and Biotech |
| Champions Biotechnology and Cephalon to Evaluate Novel Oncology Compound Using Biomerk Tumorgraft Pl | September 15, 2010 | Biotechnology - Moreover |
| Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel... | September 08, 2010 | Biotechnology - Moreover |
| Champions Biotechnology signs agreement to test Cephalon's CEP-32496 in Biomerk Tumorgraft platform | September 08, 2010 | Biotechnology - Moreover |
| Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform | September 08, 2010 | Biotech News - PR Newswire |
| Cephalon CEO checks out on medical leave | August 26, 2010 | FiercePharma |
| Cephalon CEO Frank Baldino Takes Medical Leave Of Absence | August 25, 2010 | Biotechnology - Moreover |
| Cephalon CEO, Founder Baldino Takes Medical Leave | August 25, 2010 | Health News - Fox Business |
| Cephalon CEO takes medical leave | August 25, 2010 | Health News - CNBC |
| Cephalon CEO To Take Medical Leave; Operating Chief Steps In | August 25, 2010 | Health News - Fox Business |
| Cephalon Announces Chairman and CEO to Take Medical Leave of Absence | August 25, 2010 | Biotech News - PR Newswire |
| Cephalon CEO Baldino taking medical leave | August 25, 2010 | Health News - BizJournals.com |
| Cephalon files lawsuit against company planning to sell generic Nuvigil | August 20, 2010 | Health News - BizJournals.com |
| Cephalon sues Apotex in Nuvigil patent dispute | August 19, 2010 | Health News - CNBC |
| FTC Defends Its Role in Watson-Cephalon Investigation | July 28, 2010 | Pharmaceutical - Moreover |
| Cephalon 2Q net income rises 5 percent | July 27, 2010 | Health News - CNBC |
| Cephalon Reports Record Sales and Earnings in Second Quarter 2010 | July 27, 2010 | Biotech News - PR Newswire |
| EU urges restricted use of Cephalon's Provigil | July 23, 2010 | FiercePharma |
| Cephalon says 2Q stronger than anticipated | July 21, 2010 | Health News - BizJournals.com |
| Cephalon raises 2Q earnings, sales expectations | July 21, 2010 | Health News - CNBC |
| Cephalon Expects Second Quarter 2010 Results to Exceed Previously Issued Guidance | July 21, 2010 | Medical Pharma - PR Newswire |
| Cephalon at dispute’s heart in case pitting FTC, Watson | July 05, 2010 | Health News - BizJournals.com |
| Cephalon Second Quarter 2010 Earnings Conference Call Tuesday, July 27, 2010 at 5:00 p.m. EDT | June 24, 2010 | Biotech News - PR Newswire |
| Cephalon links with two health groups | June 23, 2010 | Health News - BizJournals.com |
| Cephalon Partners with American Chronic Pain Association and the American Pharmacists Association to Expand National Initiative On the Safe and Appropriate Use of Prescription Medicines | June 23, 2010 | Pharma News - PR Newswire |
| Celator deal with Cephalon expanded | June 21, 2010 | Health News - BizJournals.com |
| Cephalon Provides Clinical Update on Phase II Study of NUVIGIL as an Adjunctive Therapy in Adults with Schizophrenia | June 02, 2010 | Pharma News - PR Newswire |
| Cephalon Faces Another Provigil Pay-For-Delay Suit | May 28, 2010 | Pharmaceutical - Moreover |
| Cephalon off to Record Start in 2010 | May 04, 2010 | Biotech News - PR Newswire |
| Cephalon Acquires Swiss Pharmaceutical Company Mepha | April 13, 2010 | Pharmaceutical - Moreover |
| Cephalon seals $615M acquisition | April 09, 2010 | Pharmaceutical - Moreover |
| Cephalon acquires Mepha Pharma from Mepha Holding | April 09, 2010 | Pharmaceutical - Moreover |
| Cephalon acquires Mepha Pharma from Mepha Holding - Zibb.com | April 09, 2010 | Pharmaceutical - Moreover |
| Cephalon completes purchase of generic drug company Mepha | April 09, 2010 | Health News - BizJournals.com |
| Cephalon Completes Mepha Acquisition | April 09, 2010 | Contract Pharma |
| Cephalon finishes acquisition of drugmaker Mepha | April 09, 2010 | Health News - CNBC |
| Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha | April 09, 2010 | Pharma News - PR Newswire |
| Mylan chief's pay tops $16M; Cephalon's drops to $11M | April 07, 2010 | FiercePharma |
| Cephalon (CEPH) Closes Acquisition of Ception Therapeutics | April 06, 2010 | Biotechnology - Moreover |
| Cephalon of Frazer completes purchase of another area company, Ception | April 06, 2010 | Health News - BizJournals.com |
| Cephalon Completes Acquisition of Ception Therapeutics / Acquisition Adds Biologics Asset for Advancement to Phase Three Development | April 05, 2010 | Biotechnology - Moreover |
| Cephalon Completes Acquisition Of Ception Therapeutics - Quick Facts | April 05, 2010 | Biotechnology - Moreover |
| Cephalon Completes Acquisition of Ception Therapeutics | April 05, 2010 | Clinical Trials - PR Newswire |
| Cephalon First Quarter 2010 Earnings Conference Call Tuesday, May 4, 2010 at 5:00 p.m. EDT | March 31, 2010 | Medical Pharma - PR Newswire |
| FDA denies Cephalon's bid for Nuvigil in jet lag | March 30, 2010 | FiercePharma |
| FDA declines to approve Cephalon's Nuvigil for jet lag | March 30, 2010 | FierceBiotech |
| Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder | March 29, 2010 | Biotech News - PR Newswire |
| Innate Immune, Inc. Enters into a License and Commercialization Agreement with Cephalon ... | March 18, 2010 | Biotechnology - Moreover |
| Innate Immune, Inc. Enters into a License and Commercialization Agreement with Cephalon Australia Pty Ltd | March 15, 2010 | Pharma News - Business Wire |
| Cephalon Inc. (CEPH) Breaks Out Of Today's Range | March 03, 2010 | Pharmaceutical - Moreover |
| Research and Markets: Partnering Agreements with Cephalon 2010 - An In-Depth Insight into One of the Worlds Leading Biopharma Companies | March 02, 2010 | Pharma News - Business Wire |
| Cephalon exercises $250M option to buy Ception | February 23, 2010 | Health News - CNBC |
| Cephalon to buy Ception of Malvern for $250M | February 23, 2010 | Health News - BizJournals.com |
| Cephalon pays $250M to snare Ception Therapeutics | February 23, 2010 | FierceBiotech |
| Cephalon Exercises its Option to Acquire Ception Therapeutics | February 23, 2010 | Medical Pharma - PR Newswire |
| Cephalon growing globally | February 22, 2010 | Health News - BizJournals.com |
| Reportlinker Adds Cephalon Inc.: PharmaVitae Profile | February 16, 2010 | Pharma News - PR Newswire |
| Alcon, Cephalon report profit growth | February 12, 2010 | FiercePharma |
| Cephalon 4Q profit jumps on sales, lower charges | February 11, 2010 | Health News - CNBC |
| Cephalon Fourth-quarter Profit Jumps To $96.6 Mln | February 11, 2010 | Health News - Fox Business |
| Week of Feb. 1, 2010: Company and People Notes: Cephalon Buys Mepha; BASi's CEO Retires; and More. | February 03, 2010 | Pharmaceutical - Moreover |
| Week Of Feb. 1, 2010: Company And People Notes: Cephalon Buys Mepha AG; BASi's CEO Retires; And More. | February 03, 2010 | Pharmaceutical - Moreover |
| Cephalon to acquire Mepha Pharma from Mepha Holding - Zibb.com | February 02, 2010 | Pharmaceutical - Moreover |
| Cephalon To Buy Swiss Drugmaker Mepha For $590M | February 02, 2010 | Pharmaceutical - Moreover |
| Cephalon acquiring Swiss drugmaker Mepha AG | February 01, 2010 | Biotechnology - Moreover |
| Cephalon to Acquire Mepha AG for $590 Million | February 01, 2010 | Health News - Fox Business |
| Cephalon Inc. (CEPH) Inks Acquisition Deal with Sales Driven, Swiss Pharmaceutical Company Mepha AG | February 01, 2010 | Pharmaceutical - Moreover |
| Cephalon nabs Switzerland's Mepha for $588M | February 01, 2010 | FiercePharma |
| Cephalon to Acquire Mepha AG | February 01, 2010 | Contract Pharma |
| Cephalon acquires Swiss drugmaker Mepha AG | February 01, 2010 | Health News - CNBC |
| Cephalon (CEPH) Acquires Mepha AG for $590M | February 01, 2010 | Pharmaceutical - Moreover |
| UPDATE 1-Cephalon to buy generic firm Mepha for $590 mln | February 01, 2010 | Pharmaceutical - Moreover |
| Cephalon To Pay $590 Million For Mepha | February 01, 2010 | Health News - Fox Business |
| Cephalon Names COO, CFO | January 29, 2010 | Pharmaceutical - Moreover |
| Cephalon Announces Executive Leadership Changes | January 28, 2010 | Biotech News - PR Newswire |
| Cephalon stops using Treanda dosing cards after FDA letter calls them misleading | January 13, 2010 | Health News - BizJournals.com |
| Mylan, Cephalon in dispute over sleep drug Nuvigil | January 11, 2010 | Health News - BizJournals.com |
| Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position | January 08, 2010 | Biotech News - PR Newswire |
| In Jet Lag, Cephalon Sees a Path to Extending a Drug Patent | January 07, 2010 | New York Times- Pharmaceuticals |
| Cephalon hikes Provigil price to push new med | December 22, 2009 | FiercePharma |
| FDA hesitates on Cephalon's jet lag drug | December 22, 2009 | FierceBiotech |
| Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder | December 21, 2009 | Pharma News - PR Newswire |
| ASH roundup: Ariad, Cephalon and Novartis make a splash | December 08, 2009 | FierceBiotech |
| Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals | December 02, 2009 | Pharma News - PR Newswire |
| Cephalon hesitates on Ception drug results | November 23, 2009 | FierceBiotech |
